Payer profits fell in 2024 as Americans, especially older ones, utilized more medical care. But efforts to resuscitate ...

Novo Nordisk Q1 sales missed estimates despite strong growth in Wegovy and Ozempic, prompting a cut to its 2025 guidance amid ...